Bo Ying PhD

Dr. Bo Ying is the founder, chairman, and CEO of Abogen Biosciences, a leading mRNA therapeutic company in China. Since 2019, Abogen has established a proprietary mRNA platform and advanced delivery technologies for the treatment of infectious diseases, autoimmune diseases, as well as cancer. Dr. Ying obtained his bachelor's and master's degrees at Fudan University and a Ph.D. in Pharmaceutical Sciences from Northeastern University in Boston. He is also the inventor of multiple innovative technologies, and his research work has been published in Cell and The Lancet.